Table 7 Median dose intensity (%) over two, four and six cycles

From: Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study

 

Two cycles

Four cycles

Six cycles

Dose level

Irinotecan

Oxaliplatin

Irinotecan

Oxaliplatin

Irinotecan

Oxaliplatin

1

100

98.2

89.6

92.1

89.5

94.5

2

100

100

82.8

82

81.8

92.3

3

100

100

100

100

100

100

4

80

66.7

85

56

85.9

62.6

Back to article page